Target intelligence / Profile preview

Innate immune system cells

Molecular classification
Other
01

Overview

The innate immune system represents the body's immediate, non-specific defense mechanism against pathogens and foreign substances (StatPearls, 2023). It is composed of diverse cell populations, including macrophages, neutrophils, dendritic cells, and natural killer (NK) cells, which utilize pattern recognition receptors (PRRs) to detect conserved microbial motifs (NIH, 2022). These cells are essential for initiating inflammatory responses, performing phagocytosis, and bridging the gap to adaptive immunity via antigen presentation (Nature Reviews Immunology, 2021). In disease contexts, overactive innate immune cells drive chronic inflammatory conditions and tissue damage, while their suppression within the tumor microenvironment can facilitate cancer progression (PubMed, 2020). Although innate immune cells are a broad category rather than a single molecular target, many drugs modulate these cells; for instance, Toll-like receptor (TLR) agonists are used as vaccine adjuvants to enhance innate activation, whereas corticosteroids provide broad immunosuppression by inhibiting inflammatory gene expression across these cell types (PubChem, 2023).

Other names
Innate immunityNon-specific immune systemInnate immune effectorsMyeloid and NK cell populations
02

Mechanism of action

Modulation of innate immune cell recruitment, activation, or effector functions through various molecular pathways including PRR signaling and cytokine modulation.

03

Biological functions

Immune responseInflammationPhagocytosisAntigen presentationCytokine productionPathogen recognition
04

Disease associations

InflammationInfectionCancerAutoimmune diseaseSepsis
05

Safety considerations

ImmunosuppressionCytokine release syndromeIncreased susceptibility to opportunistic infectionsSystemic inflammation
06

Interacting drugs

Corticosteroids

4 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)ProcalcitoninAbsolute neutrophil count (ANC)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)

Beyond the preview

Go deeper on Innate immune system cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune system cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call